Latest evidence-based view

FEM · BUY

FEM (First Trust Emerging Markets AlphaDEX Fund) reweights stocks by momentum, quality, value or another systematic factor. One-month (+4.05%) and three-month (+6.61%) returns both align with BUY.

SELLOriginal source alertBUYEvidence-reviewed stance240Alert timeframe

FEM currently supports a buy stance.

One-month (+4.05%) and three-month (+6.61%) returns both align with BUY.

The opposing case is clear: A factor regime change can cause prolonged relative underperformance. The 0.80% annual expense ratio is deducted throughout ownership. The stance remains tied to the observed price trend.

Use staged sizing and reassess when the one- and three-month trends no longer support this stance.

Market evidence

33.37Reference price

4.051-month return

6.613-month return

25.781-year return

95.452-week range position

2026-09-03T13:30:00+00:00Market data as of

Instrument profile

First Trust Emerging Markets AlphaDEX Fund

DescriptionFirst Trust Emerging Markets AlphaDEX FundSecurity TypefundSecurity SubtypeetfSectorMiscellaneousIndustryInvestment Trusts/Mutual FundsBeta 1Y1.01Expense Ratio Percent0.8Nav33.087

Referenced public sources

No article citation was required for this evidence review.